News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
204,960 Results
Type
Article (10558)
Company Profile (52)
Press Release (194350)
Multimedia
Podcasts (8)
Webinars (3)
Section
Business (64603)
Career Advice (504)
Deals (13023)
Drug Delivery (36)
Drug Development (26635)
Employer Resources (31)
FDA (5446)
Job Trends (5747)
News (109043)
Policy (8558)
Tag
Academia (819)
Accelerated approval (1)
Adcomms (3)
Allergies (34)
Alliances (12541)
ALS (22)
Alzheimer's disease (453)
Antibody-drug conjugate (ADC) (46)
Approvals (5477)
Artificial intelligence (65)
Autoimmune disease (3)
Automation (7)
Bankruptcy (74)
Best Places to Work (4595)
BIOSECURE Act (10)
Biosimilars (28)
Biotechnology (32)
Bladder cancer (32)
Brain cancer (7)
Breast cancer (110)
Cancer (816)
Cardiovascular disease (78)
Career advice (396)
Career pathing (5)
CAR-T (40)
Cell therapy (115)
Cervical cancer (10)
Clinical research (22832)
Collaboration (217)
Company closure (1)
Compensation (137)
Complete response letters (3)
COVID-19 (899)
CRISPR (14)
C-suite (37)
Cystic fibrosis (62)
Data (953)
Depression (16)
Diabetes (78)
Diagnostics (2155)
Digital health (3)
Diversity, equity & inclusion (10)
Drug discovery (27)
Drug pricing (36)
Drug shortages (4)
Duchenne muscular dystrophy (34)
Earnings (39450)
Editorial (10)
Employer branding (3)
Employer resources (31)
Events (26910)
Executive appointments (125)
FDA (5946)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (3)
Funding (240)
Gene editing (32)
Generative AI (3)
Gene therapy (107)
GLP-1 (242)
Government (1235)
Grass and pollen (4)
Guidances (113)
Healthcare (6706)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (44)
Indications (13)
Infectious disease (954)
Inflammatory bowel disease (49)
Inflation Reduction Act (4)
Influenza (18)
Intellectual property (27)
Interviews (49)
IPO (7230)
IRA (15)
Job creations (1338)
Job search strategy (359)
Kidney cancer (6)
Labor market (17)
Layoffs (190)
Leadership (2)
Legal (1579)
Liver cancer (30)
Lung cancer (137)
Lymphoma (67)
Machine learning (5)
Management (13)
Manufacturing (99)
MASH (26)
Medical device (4319)
Medtech (4319)
Mergers & acquisitions (5988)
Metabolic disorders (203)
Multiple sclerosis (28)
NASH (10)
Neurodegenerative disease (26)
Neuropsychiatric disorders (6)
Neuroscience (639)
NextGen: Class of 2025 (2197)
Non-profit (2152)
Now hiring (9)
Obesity (95)
Opinion (65)
Ovarian cancer (23)
Pain (32)
Pancreatic cancer (27)
Parkinson's disease (54)
Partnered (5)
Patents (38)
Patient recruitment (32)
Peanut (19)
People (10235)
Pharmaceutical (20)
Pharmacy benefit managers (5)
Phase I (5924)
Phase II (9800)
Phase III (8730)
Pipeline (790)
Policy (51)
Postmarket research (947)
Preclinical (2007)
Press Release (19)
Prostate cancer (29)
Psychedelics (8)
Radiopharmaceuticals (58)
Rare diseases (170)
Real estate (1914)
Recruiting (11)
Regulatory (6449)
Reports (11)
Research institute (880)
Resumes & cover letters (118)
Rett syndrome (1)
RNA editing (1)
RSV (21)
Schizophrenia (33)
Series A (27)
Series B (24)
Service/supplier (4)
Sickle cell disease (13)
Special edition (8)
Spinal muscular atrophy (58)
Sponsored (6)
Startups (873)
State (1)
Stomach cancer (3)
Supply chain (15)
Tariffs (18)
The Weekly (8)
Vaccines (266)
Venture capitalists (13)
Weight loss (61)
Women's health (5)
Worklife (3)
Date
Last 7 days (417)
Last 30 days (1103)
Last 365 days (11078)
2025 (4037)
2024 (12038)
2023 (13527)
2022 (15874)
2021 (17305)
2020 (17666)
2019 (16840)
2018 (12864)
2017 (10886)
2016 (9731)
2015 (11615)
2014 (8001)
2013 (6221)
2012 (6659)
2011 (7032)
2010 (5995)
Location
Africa (227)
Alabama (19)
Alaska (2)
Arizona (59)
Arkansas (6)
Asia (11563)
Australia (1710)
California (2098)
Canada (646)
China (203)
Colorado (96)
Connecticut (106)
Delaware (67)
Europe (29757)
Florida (307)
Georgia (57)
Idaho (14)
Illinois (182)
India (10)
Indiana (98)
Iowa (2)
Japan (66)
Kansas (47)
Kentucky (10)
Louisiana (6)
Maine (27)
Maryland (251)
Massachusetts (1589)
Michigan (62)
Minnesota (102)
Mississippi (1)
Missouri (42)
Montana (7)
Nebraska (4)
Nevada (18)
New Hampshire (37)
New Jersey (718)
New Mexico (6)
New York (597)
North Carolina (313)
North Dakota (1)
Northern California (991)
Ohio (53)
Oklahoma (3)
Oregon (13)
Pennsylvania (489)
Puerto Rico (4)
Rhode Island (6)
South America (378)
South Carolina (3)
Southern California (802)
Tennessee (32)
Texas (308)
United States (7935)
Utah (59)
Virginia (57)
Washington D.C. (12)
Washington State (186)
West Virginia (1)
Wisconsin (18)
204,960 Results for "50".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock
May 6, 2025
·
4 min read
Startups
Etiome Steps Out of Stealth With $50M to Address Disease At The ‘Silent Stage’
With a new raise provided by Flagship Pioneering, the new company is aiming to find “the silent window” before disease symptoms set in.
April 24, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Sirius Therapeutics Announces Nearly $50 Million Financing to Accelerate Clinical Development of siRNA Therapeutics for Cardiometabolic Diseases
May 9, 2025
·
1 min read
Press Releases
Avidicure Launches with $50 Million in Seed Financing to Develop New Multifunctional Antibody Modality to Treat Cancer
April 25, 2025
·
3 min read
Press Releases
Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years
April 22, 2025
·
4 min read
Deals
Sanofi Seals Deal With Private Equity Firm for 50% Stake in Consumer Healthcare Unit
Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French government taking a stake as well to ensure the business remains in the county.
October 21, 2024
·
2 min read
·
Annalee Armstrong
Vaccines
CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64
The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.
October 24, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Final Call for Biocodex Microbiota Foundation $50,000 2025 USA Microbiome Research Grant
April 2, 2025
·
2 min read
Press Releases
bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
April 17, 2025
·
6 min read
Press Releases
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection
April 29, 2025
·
3 min read
1 of 20,496
Next
